A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer

被引：0
|
作者：
Kyoung Ha Kim
Young Suk Park
Myung Hee Chang
Hyo Song Kim
Hyun Jung Jun
Jieun Uhm
Seong Yoon Yi
Do Hyoung Lim
Sang Hoon Ji
Min Jae Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Docetaxel; Oxaliplatin; Advanced gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 353
页数：6
相关论文
共 50 条
  • [21] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Dae Young Zang
    Dae Hyun Yang
    Hae Wan Lee
    Se Won Hwang
    Hun Ho Song
    Joo Young Jung
    Jung Hye Kwon
    Hyo Jung Kim
    Jung Han Kim
    Sa Rah Park
    Min-Jeong Kim
    Kyung Mi Jang
    Choong Kee Park
    Jong Hyeok Kim
    Bong Hwa Lee
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 509 - 516
  • [22] A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
    Rischin, D
    Boyer, M
    Smith, J
    Millward, M
    Michael, M
    Bishop, J
    Zalcberg, J
    Davison, J
    Emmett, E
    McClure, B
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 421 - 426
  • [23] PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER
    Utelbayeva, A.
    Arzykulov, Z.
    Izhanov, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 45 - 46
  • [24] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [25] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [26] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
  • [27] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
    K Yamaguchi
    T Shimamura
    I Hyodo
    W Koizumi
    T Doi
    H Narahara
    Y Komatsu
    T Kato
    S Saitoh
    T Akiya
    M Munakata
    Y Miyata
    Y Maeda
    H Takiuchi
    S Nakano
    T Esaki
    F Kinjo
    Y Sakata
    British Journal of Cancer, 2006, 94 : 1803 - 1808
  • [28] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Kwon, K.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Park, Y.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
  • [30] Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer
    Al-Batran, SE
    Atmaca, A
    Hegewisch-Becker, S
    Jaeger, D
    Hahnfeld, S
    Rummel, MJ
    Seipelt, G
    Rost, A
    Knuth, JOA
    Jaeger, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) : 658 - 663
12345